Acute renal failure during the “off” period after sunitinib administration: Possible mechanism of vascular endothelial growth factor cascade hyperactivation
Open Access
- 9 May 2013
- journal article
- letter
- Published by Wiley in International Journal of Urology
- Vol. 20 (11) , 1149-1150
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell CarcinomaEuropean Journal of Cancer, 2011
- Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markersBMC Cancer, 2009
- Losartan Metabolite EXP3179 Activates Akt and Endothelial Nitric Oxide Synthase via Vascular Endothelial Growth Factor Receptor-2 in Endothelial CellsCirculation, 2005
- Tumor angiogenesis and accessibility: Role of vascular endothelial growth factorSeminars in Oncology, 2002